Table 2. Incubation periods and clinical presentations of iatrogenic Creutzfeldt-Jakob disease, according to source of infection*.
Source of Infection | No. cases | Mean incubation period, y (range) | Clinical signs† |
---|---|---|---|
Dura mater graft | 228 | 12 (1.3–30) | Cerebellar, visual, dementia |
Neurosurgical instruments | 4 | 1.4 (1–2.3) | Visual, dementia, cerebellar |
Stereotactic EEG needles | 2 | 1.3, 1.7 | Dementia, cerebellar |
Corneal transplant | 2 | 1.5, 27 | Dementia, cerebellar |
Growth hormone | 226 | 17 (5–42)‡ | Cerebellar |
Gonadotropin | 4 | 13.5 (12–16) | Cerebellar |
Packed red blood cells§ | 3 | 6.5, 7.8, 8.3 | Psychiatric, sensory, dementia, cerebellar |
*EEG, electroencephalogram. †In order of decreasing frequency. ‡Averages and ranges were 13 (5–24) y in France; 20 (7–39) y in the United Kingdom; and 22 (10–42) y in the United States. §An additional asymptomatic but infected red-cell recipient died of an unrelated illness; another asymptomatic infected hemophilia patient who had been exposed to potentially contaminated factor VIII also died of an unrelated illness (neither is included in the table).